|
|
|
|
|
 |
| |
|
Salida Mirzoeva, PhD
Research Assistant Professor of Pathology
Lurie 3-250
303 E. Chicago Avenue
Chicago, IL 60611
smi884@northwestern.edu
|
|
|
Phone: (312) 503-0332
|
Medical School
Russian Academy of Sciences (PhD)
Site of Fellowship
Vanderbilt University Medical School
/ Northwestern University Feinberg School of Medicine
Research Interests
I am interested in signal transduction of cancer and particularly of solid tumors and development of new strategies for chemoprevention of cancer. Currently my studies are focused on signaling pathways that are activated by tumor microenvironment, particularly on cell responses to hypoxic conditions. I use human prostate cancer cells to develop small molecule drugs that exploit the unique hypoxia of solid tumors.
Selected Publications
Corbould A, Zhao H, Mirzoeva S, Aird F, Dunaif A. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes. 55:751-9, 2006
Mirzoeva S, Kim ND,Chiu K, Franzen CA, Bergan RC, Pelling JC. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Mol. Carcinog. 47:686-700, 2008.
View more Publications by Salida Mirzoeva, PhD
listed in the National Library of Medicine (PubMed)
|
|
|
| |
|
|
|
|
|
|
|
|
